Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

scientific article

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/DKQ415
P698PubMed publication ID21081548
P5875ResearchGate publication ID47809041

P50authorBenjamin A RogersQ57046471
David L PatersonQ59993174
P2093author name stringHanna E Sidjabat
P2860cites workNHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007Q28298371
Virulence factors in Escherichia coli urinary tract infectionQ28468751
Sex and virulence in Escherichia coli: an evolutionary perspectiveQ28768050
The CTX-M beta-lactamase pandemic.Q30356558
Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.Q30369226
Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.Q30385107
Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide studyQ30389929
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.Q33464072
Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, IndonesiaQ33522349
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipientsQ33558863
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICsQ33762110
Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana.Q33769980
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in womenQ33853747
Rapid and simple determination of the Escherichia coli phylogenetic groupQ33919655
Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosisQ34046488
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcomeQ34106854
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).Q34135508
Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond EuropeQ34198709
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomeQ34351978
The worldwide emergence of plasmid-mediated quinolone resistanceQ34569740
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella speciesQ34680546
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcomeQ35007119
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the communityQ36139832
Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, ItalyQ36423625
Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typingQ36497922
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitisQ36845365
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized studyQ36880729
Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, FranceQ36994434
Endemic and epidemic lineages of Escherichia coli that cause urinary tract infectionsQ37028442
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structuresQ37144817
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health RegionQ37204201
Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infectionsQ37247785
Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004Q37247793
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 cloneQ37392921
Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.Q37409886
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritisQ37410500
Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, CanadaQ37568365
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapyQ37624439
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choicesQ37694529
Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamasesQ39671119
Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strainsQ39787461
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community settingQ39991540
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroupQ40003526
UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 cloneQ40049656
Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in SpainQ40328763
Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15.Q41900712
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from CanadaQ42111425
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecyclineQ42549433
CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, PhilippinesQ42574879
Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a householdQ42613485
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United StatesQ43007779
Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in AustraliaQ43008614
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluationQ43105699
Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infectionsQ43108510
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitalsQ43111830
Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factorsQ43147921
Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patientsQ43198027
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignanciesQ43206339
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.Q43215478
Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in KoreaQ43237115
CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.Q43293884
Detection of beta-lactamase-mediated resistanceQ43649165
Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spreadQ44678593
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamasesQ44943295
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.Q45044150
Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New ZealandQ45138244
Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium.Q45140912
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.Q45236129
Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal groupQ45278057
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.Q45956390
Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.Q45956989
Emergence of imipenem resistance in clinical Escherichia coli during therapyQ46385100
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.Q46852401
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseQ46862305
Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamasesQ47607784
Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamasesQ47653135
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strainsQ47714144
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.Q48070401
A novel IS26 structure surrounds blaCTX-M genes in different plasmids from German clinical Escherichia coli isolates.Q51788193
AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.Q53174362
High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.Q54160713
Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection.Q54394408
Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.Q54404451
Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system.Q54405525
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia.Q54454379
Escherichia coli ST131 producing CTX-M-15 in AustraliaQ58455470
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
multiple drug resistanceQ643839
pandemicQ12184
P304page(s)1-14
P577publication date2010-11-16
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleEscherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
P478volume66

Reverse relations

cites work (P2860)
Q37109522A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
Q27011287A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131
Q40863067A potential camel reservoir for extended-spectrum β-lactamase-producing Escherichia coli causing human infection in Saudi Arabia
Q36276987A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone
Q36607290Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli
Q51298402An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area.
Q31015114Analysis of the Structure and Function of FOX-4 Cephamycinase.
Q36933460Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey
Q100533695Antibiotic resistance and virulence of Escherichia coli strains isolated from animal rendering plant
Q34299012Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model
Q41104461Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia
Q51547630Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes.
Q46701351Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies
Q36757725Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?
Q39044602Application of genomic technologies to measure and monitor antibiotic resistance in animals
Q34084784Are subinhibitory concentrations of antibiotics the only culprit of antibiotic resistance?
Q41188253Assessment of the Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Ready-to-Eat Salads, Fresh-Cut Fruit, and Sprouts from the Swiss Market.
Q37979685Association between antimicrobial resistance and virulence in Escherichia coli.
Q37263765Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups.
Q34085171Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality
Q35607916Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.
Q30390256Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.
Q30415141CTX-M Enzymes: Origin and Diffusion
Q37335144CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA.
Q30357611CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
Q30407533CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents
Q41480033CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic
Q92603347Carriage and population genetics of extended spectrum β-lactamase-producing Escherichia coli in cats and dogs in New Zealand
Q40410184Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand
Q36667293Characteristics of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains Isolated from Multiple Rivers in Southern Taiwan.
Q30427771Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland
Q54291041Characterization of CTX-M-producing Escherichia coli by repetitive sequence-based PCR and real-time PCR-based replicon typing of CTX-M-15 plasmids.
Q41679953Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study.
Q34270772Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK.
Q50239001Characterization of Extended Spectrum Β-Lactamase Producing Enterobacteria and Methicillin-Resistant Staphylococcus aureus Isolated from Raw Pork and Cooked Pork Products in South China
Q34236871Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131.
Q37026386Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Q53729611Characterization of four Escherichia coli clonal groups.
Q36086484Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010)
Q52300037Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK.
Q36544359Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
Q41595384Clinical and microbiological determinants of infection after transrectal prostate biopsy
Q54307864Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy.
Q34596560Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli
Q37001723Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period
Q35607768Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648
Q36357629Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Q94545197Clinically Relevant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates From Food Animals in South Korea
Q36505534Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections
Q36505381Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries
Q35192273Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death
Q36584908Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States
Q30358381Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.
Q30395087Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan
Q35289728Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus
Q40702546Comparative virulotyping of extended-spectrum cephalosporin-resistant E. coli isolated from broilers, humans on broiler farms and in the general population and UTI patients
Q35082753Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria
Q40028752Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.
Q34995541Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli
Q47153650Complete genome sequencing and genomic characterization of two Escherichia coli strains co-producing MCR-1 and NDM-1 from bloodstream infection
Q33622996Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China
Q33581179Comprehensive Diagnosis of Bacterial Infection Associated with Acute Cholecystitis Using Metagenomic Approach
Q36025192Current epidemiology and growing resistance of gram-negative pathogens
Q36086414Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada
Q40095174Detection of CTX-M-15 Among Uropathogenic Escherichia coli Isolated from Five Major Hospitals in Tripoli, Libya
Q43219324Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae
Q37618320Detection of aac(6')-Ib-cr in avian pathogenic Escherichia coli isolates in Japan
Q38853303Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry
Q40079140Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain
Q33899432Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.
Q34983886Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates
Q30371400Dissemination of IncF-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from surgical-site infections in Bangui, Central African Republic
Q36018946Dissemination of pCT-like IncK plasmids harboring CTX-M-14 extended-spectrum β-lactamase among clinical Escherichia coli isolates in the United Kingdom
Q36078069Diversity of Escherichia coli strains involved in vertebral osteomyelitis and arthritis in broilers in Brazil
Q41006973Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia
Q42277748Draft Genome Sequence Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in 2013 from Humans and Chickens in Nigeria
Q40075817Draft Genome Sequence of blaNDM-1-Positive Escherichia coli O25b-ST131 Clone Isolated from an Environmental Sample.
Q41790141Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in Australia
Q36951570Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
Q57794294Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study
Q37876027Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance
Q40945695Ecology of antimicrobial resistance: Special aspects of extended-spectrum β-lactamases
Q54340974Editorial comment to genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
Q30419770Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan
Q51846180Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy.
Q41907702Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China
Q40294249Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China
Q39101630Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections
Q34575092Epidemic plasmid carrying bla(CTX-M-15) in Klebsiella penumoniae in China
Q28073332Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis
Q41928155Epidemiological characterization of a nosocomial outbreak of extended spectrum β-lactamase Escherichia coli ST-131 confirms the clinical value of core genome multilocus sequence typing
Q38784666Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli
Q37036459Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
Q53704499Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.
Q42559358Escherichia coli ST131: variations on a theme of clonal expansion
Q53133655Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
Q27015697Escherichia coli in Europe: an overview
Q43230989Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy
Q42574094Escherichia coli producing CMY-2 β-lactamase in retail chicken, Pittsburgh, Pennsylvania, USA.
Q37264321Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women
Q37562424Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts
Q38201515Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Q26749590Escherichia coli β-Lactamases: What Really Matters
Q38270555Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli
Q28365034Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden
Q30373052Evaluation of a Method Using Three Genomic Guided Escherichia coli Markers for Phylogenetic Typing of E. coli Isolates of Various Genetic Backgrounds
Q38074212Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).
Q36727688Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131
Q31105455Evolutionary analyses of non-genealogical bonds produced by introgressive descent
Q35630038Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution?
Q34738249Extended-spectrum Beta-lactamase gene sequences in gram-negative saprophytes on retail organic and nonorganic spinach
Q57930070Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
Q35366256Extended-spectrum-β-lactamase-producing Enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam.
Q64885968Extra-Intestinal Fluoroquinolone-Resistant Escherichia coli Strains Isolated from Meat.
Q40045567Faecal carriage of CTX-M extended-spectrum beta-lactamase-producing Enterobacteriaceae among street children dwelling in Mwanza city, Tanzania
Q36379396Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.
Q57031016Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico
Q55472567Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.
Q40240170First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran
Q35066516First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America.
Q37264353Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.
Q34494097Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, Germany
Q40988658Genetic Contexts of blaNDM-1 in Patients Carrying Multiple NDM-Producing Strains
Q40263075Genetic characterization of fluoroquinolone resistant Escherichia coli from urban streams and municipal and hospital effluents.
Q52640052Genetic contexts related to the diffusion of plasmid-mediated CTX-M-55 extended-spectrum beta-lactamase isolated from Enterobacteriaceae in China.
Q40116355Genome analysis of E. coli isolated from Crohn's disease patients
Q42849959Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India
Q36439160Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts
Q90658001Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones
Q34597880Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India
Q47106212Genotypic characterization of gentamicin and cephalosporin resistant Escherichia coli isolates from blood cultures in a Norwegian university hospital 2011-2015.
Q90218796Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
Q37711903Global dissemination of a multidrug resistant Escherichia coli clone
Q36337074Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Q36306912Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli
Q34237433High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam
Q44784055High-throughput phenotyping of uropathogenic E. coli isolates with Fourier transform infrared spectroscopy.
Q35960769Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal
Q64988793Identification of specific protein amino acid substitutions of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli ST131: a proteomics approach using mass spectrometry.
Q42244650Implementation of Fourier transform infrared spectroscopy for the rapid typing of uropathogenic Escherichia coli.
Q35584285Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure
Q38802022Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned
Q36513085Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota
Q38221132Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis
Q40656286Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study
Q91995139Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study
Q39888407Industry survey of Great Britain-sourced broilers for extended-spectrum beta-lactamase and Amp C beta-lactamase-producing Escherichia coli
Q33887625Infections caused by fluoroquinolone-resistant Escherichia coli following transrectal ultrasound-guided biopsy of the prostate
Q38093459Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli
Q41348043Insight into neonatal septicaemic Escherichia coli from India with respect to phylogroups, serotypes, virulence, extended-spectrum-β-lactamases and association of ST131 clonal group.
Q35654610Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs
Q41220729Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli
Q39112302Lineages and virulence gene content among extended-spectrum β-lactamase-producing Escherichia coli strains of food origin in Tunisia
Q35628250Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli
Q41741261MLST reveals potentially high-risk international clones of Enterobacter cloacae
Q46147802Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan
Q92491726Meta-analysis of Pandemic Escherichia coli ST131 Plasmidome Proves Restricted Plasmid-clade Associations
Q27000929Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone
Q40876635Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.
Q37504205Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.
Q57024804Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China
Q35602248Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone
Q43097212Molecular characterization of bla ESBL-harboring conjugative plasmids identified in multi-drug resistant Escherichia coli isolated from food-producing animals and healthy humans
Q37026462Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing
Q34675362Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar
Q57031890Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia
Q35941378Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
Q41438937Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China
Q34783513Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems
Q34315040Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
Q39485718Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings
Q37263634Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients.
Q31079625Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones
Q35648493Multidrug-Resistant and Extended Spectrum Beta-Lactamase-Producing Escherichia coli in Dutch Surface Water and Wastewater
Q38389612Multidrug-resistant Escherichia coli in Asia: epidemiology and management
Q37887250Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods
Q40631519Multilocus sequence typing and CTX-M characterization of ESBL-producing E. coli: a prospective single-centre study in Lower Saxony, Germany
Q42638080Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30.
Q34163308Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Q41182987Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage
Q43521824National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain
Q34694361Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals
Q36994466Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar
Q64118672No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017
Q33837065No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitals
Q89823888Non-viable chicken embryos: an overlooked niche harbouring a significant source of multidrug resistant bacteria in the poultry production
Q37409839Novel Phagocytosis-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli From Keratitis
Q33657304Novel genes associated with enhanced motility of Escherichia coli ST131.
Q42665561Nucleotide sequences of 16 transmissible plasmids identified in nine multidrug-resistant Escherichia coli isolates expressing an ESBL phenotype isolated from food-producing animals and healthy humans
Q54321125Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
Q38945913Occurrence of IMP-8, IMP-10, and IMP-13 metallo-β-lactamases located on class 1 integrons and other extended-spectrum β-lactamases in bacterial isolates from Tunisian rivers.
Q39156803Occurrence of conjugative IncF-type plasmids harboring the blaCTX-M-15 gene in Enterobacteriaceae isolates from newborns in Tunisia
Q36826739Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory
Q39517366Outbreak of colonizations by extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy
Q36204123Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
Q34035610Overlapped sequence types (STs) and serogroups of avian pathogenic (APEC) and human extra-intestinal pathogenic (ExPEC) Escherichia coli isolated in Brazil
Q31047716Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study
Q53811523Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
Q50048560Persistent pandemic lineages of uropathogenic Escherichia coli in a college community-1999-2017.
Q36172185Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Q42119865Phylogenetic grouping and virulence potential of extended-spectrum-β-lactamase-producing Escherichia coli strains in cattle
Q41027366Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
Q91762200Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections
Q30240591Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.
Q92602528Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection
Q30397339Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance
Q34057927Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.
Q41372349Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014.
Q37026380Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark
Q54261009Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in spring waters.
Q35589184Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia
Q30401450Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs
Q36172561Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population
Q57300295Prevalence of Multidrug Resistance and Extended-Spectrum -Lactamase Carriage of Clinical Uropathogenic Isolates in Riyadh, Saudi Arabia
Q40562293Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases
Q41010675Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy
Q46949126Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
Q36174026Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013.
Q37586998Prevalent combination of virulence and plasmidic-encoded resistance in ST 131 Escherichia coli strains
Q42931296Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone
Q27001490Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
Q37623615Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.
Q36086404Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia
Q38780024Public health risk of antimicrobial resistance transfer from companion animals.
Q37713679Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.
Q34916386Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.
Q54328207Real-time PCR for detection of blaOXA-48 genes from stools.
Q35364501Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli.
Q37349628Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.
Q37998398Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example
Q36295546Resistance to antimicrobial drugs in different surface waters and wastewaters of Guadeloupe
Q37290720Resistant gram-negative infections in the outpatient setting in Latin America
Q46919326Risk Factors and Molecular Features of Sequence Type (ST) 131 Extended-spectrum β-Lactamase-producing Escherichia coli in Community-onset Bacteremia
Q54992441Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
Q36558824Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli
Q39090124Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Q50097358Selection of ESBL-Producing E. coli in a Mouse Intestinal Colonization Model.
Q38391440Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
Q41934448Silver resistance genes are overrepresented among Escherichia coli isolates with CTX-M production
Q28600869Social structure and Escherichia coli sharing in a group-living wild primate, Verreaux's sifaka
Q37713676Spread of CTX-M-15 extended-spectrum β-lactamase-producing Escherichia coli isolates through household contact and plasmid transfer
Q36902491Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.
Q38294759Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization
Q28082571Surveillance of antibiotic resistance
Q42259493Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases
Q54320019Survival of pathogenic Escherichia coli on basil, lettuce, and spinach.
Q42930222Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans
Q37458279Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
Q30393531Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics
Q36061308Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe
Q34596717Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.
Q34431394The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities
Q47158818The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015
Q97071024The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016
Q97072646The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
Q57035779The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131
Q35120750The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide
Q41220445The challenges of treating women with recurrent urinary tract infections in primary care: a qualitative study of GPs' experiences of conventional management and their attitudes towards possible herbal options
Q30375493The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.
Q38497797The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae
Q48044609The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Q34465593The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China.
Q37408471The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx
Q40299603The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome
Q90101011The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone
Q35158603The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli
Q38197399The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology
Q36262549The role of H4 flagella in Escherichia coli ST131 virulence
Q35008859The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.
Q48055285Transfer of an Escherichia coli ST131 multiresistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak.
Q36218305Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting
Q60924381Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database
Q36683661Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects
Q35071905Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
Q39921783Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.
Q40041086Uropathogenic Escherichia coli ST131 in urinary tract infections in children
Q35960847Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations
Q43088258Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.
Q64119449Virulence factors, prevalence and potential transmission of extraintestinal pathogenic isolated from different sources: recent reports
Q35867575Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype
Q30414720Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131.
Q40188898Wastewater treatment plants release large amounts of extended-spectrum β-lactamase-producing Escherichia coli into the environment.
Q35746364Who is leading this dance? Understanding the spread of Escherichia coli sequence type 131
Q58793609Whole genome analyses of CMY-2-producing Escherichia coli isolates from humans, animals and food in Germany
Q40064103Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand
Q91899356Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria
Q64236885Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes
Q30389643Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula
Q37942654Will new antimicrobials overcome resistance among Gram-negatives?
Q42203025blaCTX-M-₁₅-carrying Escherichia coli and Salmonella isolates from livestock and food in Germany.
Q36644786β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
Q37035803β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula

Search more.